de Berny Quentin, Salle Valéry, Renard Cédric, Merle Philippe-Edouard, Guilain Nelly, Choukroun Gabriel, Morel Pierre, Fourdinier Ophélie
Department of Nephrology Dialysis Transplantation, Amiens University Hospital, 1 Rue du Professeur Christian Cabrol, Amiens, 80054, France.
Department of Internal Medicine, Amiens University Hospital, Amiens, France.
BMC Musculoskelet Disord. 2025 Jul 4;26(1):615. doi: 10.1186/s12891-025-08847-x.
Vacuolar myopathy is a muscle disease characterized by inefficient autophagy and the accumulation of intracytoplasmic degradation products in autophagic vacuoles. Acquired vacuolar myopathy associated with monoclonal gammopathy is a novel clinical entity first described in 2019. The objective of the present article is to describe the first case of an acquired vacuolar myopathy associated with lambda light chain myeloma.
A 52-year-old man was admitted to our nephrology department for acute kidney injury and was diagnosed with lambda light chain multiple myeloma. The patient presented with supraventricular arrythmia and developed rapidly progressing muscle weakness of the face and all four limbs, with a myogenic electromyographic pattern. A muscle biopsy highlighted muscle fibre vacuoles and lambda light chain deposits. Cardiac magnetic resonance imaging revealed concentric hypertrophy and subepicardial areas of fibrosis that were suggestive of an infiltrative disease. There were no signs of amyloidosis. Treatment with a combination of bortezomib, lenalidomide and dexamethasone gave a good hematologic response, and the patient recovered near-normal levels of muscle strength in the following six months. The number of episodes of arrythmia decreased.
Clinicians should be aware that lambda light chain myeloma may cause lambda light-chain deposits within muscle fibres and vacuolar myopathy. A corticosteroid-sparing strategy for vacuolar myopathy does not appear to be necessary when the course of the myeloma is favourable. Myopathy associated with monoclonal gammopathy is an emerging entity. Given that monoclonal gammopathy is very common in older adults, the appearance of muscle impairments in this context could prompt the physician to consider the initiation of corticosteroids, immunosuppressive agents, or intravenous immunoglobulins. Electromyography and muscle biopsy results can guide the diagnosis.
空泡性肌病是一种肌肉疾病,其特征为自噬功能低下以及自噬泡内胞质降解产物的蓄积。与单克隆丙种球蛋白病相关的获得性空泡性肌病是2019年首次描述的一种新型临床实体。本文的目的是描述首例与λ轻链骨髓瘤相关的获得性空泡性肌病病例。
一名52岁男性因急性肾损伤入住我们的肾病科,被诊断为λ轻链多发性骨髓瘤。该患者出现室上性心律失常,并迅速出现面部和四肢肌肉无力且进行性加重,肌电图表现为肌源性。肌肉活检显示肌纤维空泡和λ轻链沉积。心脏磁共振成像显示同心性肥厚和心外膜下纤维化区域,提示为浸润性疾病。无淀粉样变性迹象。硼替佐米、来那度胺和地塞米松联合治疗取得了良好的血液学反应,患者在接下来的六个月中肌肉力量恢复到接近正常水平。心律失常发作次数减少。
临床医生应意识到λ轻链骨髓瘤可能导致肌纤维内λ轻链沉积和空泡性肌病。当骨髓瘤病程良好时,似乎没有必要采取保留皮质类固醇的空泡性肌病治疗策略。与单克隆丙种球蛋白病相关的肌病是一种新兴实体。鉴于单克隆丙种球蛋白病在老年人中非常常见,在此背景下出现肌肉损伤可能促使医生考虑开始使用皮质类固醇、免疫抑制剂或静脉注射免疫球蛋白。肌电图和肌肉活检结果可指导诊断。